Integra Lifesciences (IL3) Q2 2021 Earnings Report
0 Followers
DE:IL3 Q2 2021 EPS Results
- Actual EPS
- EUR 0.71
- Consensus EPS
- EUR 0.59
- Beat/Miss
- Beat by +EUR 0.12
- One Year Ago EPS
- EUR 0.30
DE:IL3 Q2 2021 Revenue Results
- Actual Revenue
- EUR 349.10M
- Expected Revenue
- EUR 336.68M
- Beat/Miss
- Beat by +EUR 12.43M
- YoY Revenue Growth
- +50.77%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/28/2021
- Time
- Before Open
- Conference Call
- Wednesday, July 28, 2021
DE:IL3 Upcoming Earnings
Integra Lifesciences's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IL3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | 0.58- | 0.74 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 0.500.53 | 0.48 | 9.26% (+0.04) | |
| Jul 29, 2026 | 2026 (Q2) | 0.430.50 | 0.4 | 24.44% (+0.10) | |
| May 05, 2026 | 2026 (Q1) | 0.360.48 | 0.37 | 31.71% (+0.12) | |
| Feb 26, 2026 | 2025 (Q4) | 0.720.74 | 0.87 | -14.43% (-0.13) | |
| Oct 30, 2025 | 2025 (Q3) | 0.390.48 | 0.37 | 31.71% (+0.12) | |
| Jul 31, 2025 | 2025 (Q2) | 0.390.40 | 0.56 | -28.57% (-0.16) | |
| May 05, 2025 | 2025 (Q1) | 0.390.37 | 0.49 | -25.45% (-0.13) | |
| Feb 25, 2025 | 2024 (Q4) | 0.760.87 | 0.8 | 8.99% (+0.07) | |
| Nov 04, 2024 | 2024 (Q3) | 0.350.37 | 0.68 | -46.05% (-0.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
